245 related articles for article (PubMed ID: 25415048)
1. MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis.
Yan W; Li R; Liu Y; Yang P; Wang Z; Zhang C; Bao Z; Zhang W; You Y; Jiang T
Oncotarget; 2014 Dec; 5(24):12908-15. PubMed ID: 25415048
[TBL] [Abstract][Full Text] [Related]
2. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
[TBL] [Abstract][Full Text] [Related]
3. A 4-miRNA signature to predict survival in glioblastomas.
Hermansen SK; Sørensen MD; Hansen A; Knudsen S; Alvarado AG; Lathia JD; Kristensen BW
PLoS One; 2017; 12(11):e0188090. PubMed ID: 29136645
[TBL] [Abstract][Full Text] [Related]
4. Microarray analysis of the aberrant microRNA expression pattern in gliomas of different grades.
Zhu XP; Mou KJ; Xu QF; Tang JH; Huang GH; Xu JP; Li GH; Ai SJ; Hugnot JP; Zhou Z; Lv SQ
Oncol Rep; 2015 Jul; 34(1):318-24. PubMed ID: 25954994
[TBL] [Abstract][Full Text] [Related]
5. Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
Visani M; de Biase D; Marucci G; Cerasoli S; Nigrisoli E; Bacchi Reggiani ML; Albani F; Baruzzi A; Pession A;
Mol Oncol; 2014 Mar; 8(2):417-30. PubMed ID: 24412053
[TBL] [Abstract][Full Text] [Related]
6. Role of microRNAs Located on Chromosome Arm 10q in Malignant Gliomas.
Wolter M; Werner T; Malzkorn B; Reifenberger G
Brain Pathol; 2016 May; 26(3):344-58. PubMed ID: 26223576
[TBL] [Abstract][Full Text] [Related]
7. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
8. Identification and functional characterization of microRNAs involved in the malignant progression of gliomas.
Malzkorn B; Wolter M; Liesenberg F; Grzendowski M; Stühler K; Meyer HE; Reifenberger G
Brain Pathol; 2010 May; 20(3):539-50. PubMed ID: 19775293
[TBL] [Abstract][Full Text] [Related]
9. A miRNA signature for defining aggressive phenotype and prognosis in gliomas.
Barbano R; Palumbo O; Pasculli B; Galasso M; Volinia S; D'Angelo V; Icolaro N; Coco M; Dimitri L; Graziano P; Copetti M; Valori VM; Maiello E; Carella M; Fazio VM; Parrella P
PLoS One; 2014; 9(10):e108950. PubMed ID: 25279461
[TBL] [Abstract][Full Text] [Related]
10. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of the functional microRNA-mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression.
Li Y; Xu J; Chen H; Bai J; Li S; Zhao Z; Shao T; Jiang T; Ren H; Kang C; Li X
Nucleic Acids Res; 2013 Dec; 41(22):e203. PubMed ID: 24194606
[TBL] [Abstract][Full Text] [Related]
12. Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients.
Sana J; Radova L; Lakomy R; Kren L; Fadrus P; Smrcka M; Besse A; Nekvindova J; Hermanova M; Jancalek R; Svoboda M; Hajduch M; Slampa P; Vyzula R; Slaby O
Carcinogenesis; 2014 Dec; 35(12):2756-62. PubMed ID: 25322872
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of microRNA-21 expression in gliomas: a meta-analysis.
Li C; Sun J; Xiang Q; Liang Y; Zhao N; Zhang Z; Liu Q; Cui Y
J Neurooncol; 2016 Oct; 130(1):11-17. PubMed ID: 27531352
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes.
Liu F; Gong J; Huang W; Wang Z; Wang M; Yang J; Wu C; Wu Z; Han B
Oncogene; 2014 Oct; 33(40):4813-22. PubMed ID: 24166509
[TBL] [Abstract][Full Text] [Related]
15. Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma.
Ma X; Yoshimoto K; Guan Y; Hata N; Mizoguchi M; Sagata N; Murata H; Kuga D; Amano T; Nakamizo A; Sasaki T
Neuro Oncol; 2012 Sep; 14(9):1153-62. PubMed ID: 22844109
[TBL] [Abstract][Full Text] [Related]
16. Identification of IGF-1-enhanced cytokine expressions targeted by miR-181d in glioblastomas via an integrative miRNA/mRNA regulatory network analysis.
Ho KH; Chen PH; Hsi E; Shih CM; Chang WC; Cheng CH; Lin CW; Chen KC
Sci Rep; 2017 Apr; 7(1):732. PubMed ID: 28389653
[TBL] [Abstract][Full Text] [Related]
17. Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma.
Nayak S; Aich M; Kumar A; Sengupta S; Bajad P; Dhapola P; Paul D; Narta K; Purkrait S; Mehani B; Suri A; Chakraborty D; Mukhopadhyay A; Sarkar C
Sci Rep; 2018 May; 8(1):7673. PubMed ID: 29769662
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
[TBL] [Abstract][Full Text] [Related]
19. Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.
Chang C; Shi H; Wang C; Wang J; Geng N; Jiang X; Wang X
Neurosci Lett; 2012 Dec; 531(2):204-8. PubMed ID: 23103713
[TBL] [Abstract][Full Text] [Related]
20. Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme.
Yan W; Zhang W; Sun L; Liu Y; You G; Wang Y; Kang C; You Y; Jiang T
Brain Res; 2011 Sep; 1411():108-15. PubMed ID: 21831363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
